MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 208 filers reported holding MIRATI THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $204,000 | -79.5% | 2,483 | -92.0% | 0.02% | -77.8% |
| Q4 2021 | $994,000 | +328.4% | 31,058 | -41.0% | 0.09% | +718.2% |
| Q3 2021 | $232,000 | -94.1% | 52,600 | -17.1% | 0.01% | -95.9% |
| Q1 2021 | $3,933,000 | +814.7% | 63,424 | +6.4% | 0.27% | +610.5% |
| Q4 2020 | $430,000 | -48.3% | 59,600 | +140.3% | 0.04% | -72.1% |
| Q3 2020 | $832,000 | +1469.8% | 24,801 | +46.8% | 0.14% | +1411.1% |
| Q2 2020 | $53,000 | -80.7% | 16,900 | -48.3% | 0.01% | -85.7% |
| Q1 2020 | $275,000 | -89.9% | 32,700 | -13.1% | 0.06% | -73.3% |
| Q4 2019 | $2,716,000 | – | 37,638 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
| Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
| Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
| Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
| Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
| Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
| EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
| Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
| RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |